![]() Algernon Pharmaceuticals Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ![]() Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | ||
Founding Date | Founding Date N/A | Founding Date 1904 | Founding Date 1978 | Founding Date 1951 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Vancouver, CA HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | |
Employees | Employees N/A | Employees 7,5692% decrease | Employees 7,605 | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 1.6 m | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ($1.7m) (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A |
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company